CODIFI (Concordance in Diabetic Foot Ulcer Infection): a Cross-sectional Study of Wound Swab Versus Tissue Sampling in Infected Diabetic Foot Ulcers in England

Overview

Journal BMJ Open

Specialty General Medicine

Date 2018 Feb 3

PMID 29391370

Citations 26

Authors

Andrea Nelson

Alexandra Wright-Hughes

Michael Ross Backhouse

Benjamin A Lipsky

Jane Nixon

Moninder S Bhogal

Catherine Reynolds

Sarah Brown

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the extent of agreement and patterns of disagreement between wound swab and tissue samples in patients with an infected diabetic foot ulcer (DFU).

Design: Multicentre, prospective, cross-sectional study.

Setting: Primary and secondary care foot ulcer/diabetic outpatient clinics and hospital wards across England.

Participants: Inclusion criteria: consenting patients aged ≥18 years; diabetes mellitus; suspected infected DFU.

Exclusion Criteria: clinically inappropriate to take either sample.

Interventions: Wound swab obtained using Levine's technique; tissue samples collected using a sterile dermal curette or scalpel.

Outcome Measures: Coprimary: reported presence, and number, of pathogens per sample; prevalence of resistance to antimicrobials among likely pathogens. Secondary: recommended change in antibiotic therapy based on blinded clinical review; adverse events; sampling costs.

Results: 400 consenting patients (79% male) from 25 centres.Most prevalent reported pathogens were (43.8%), (16.7%) and other aerobic Gram-positive cocci (70.6%). At least one potential pathogen was reported from 70.1% of wound swab and 86.1% of tissue samples. Pathogen results differed between sampling methods in 58% of patients, with more pathogens and fewer contaminants reported from tissue specimens.The majority of pathogens were reported significantly more frequently in tissue than wound swab samples (P<0.01), with equal disagreement for and Blinded clinicians more often recommended a change in antibiotic regimen based on tissue compared with wound swab results (increase of 8.9%, 95% CI 2.65% to 15.3%). Ulcer pain and bleeding occurred more often after tissue collection versus wound swabs (pain: 9.3%, 1.3%; bleeding: 6.8%, 1.5%, respectively).

Conclusion: Reports of tissue samples more frequently identified pathogens, and less frequently identified non-pathogens compared with wound swab samples. Blinded clinicians more often recommended changes in antibiotic therapy based on tissue compared with wound swab specimens. Further research is needed to determine the effect of the additional information provided by tissue samples.

Trial Registration Number: ISRCTN52608451.

Citing Articles

Identifying multidrug-resistant organisms in diabetic foot ulcers: a study of risk factors and antimicrobial resistance genes.

Saleem M, Moursi S, Altamimi T, Salem A, Alaskar A, Hammam S World J Microbiol Biotechnol. 2024; 41(1):3.

PMID: 39690319 DOI: 10.1007/s11274-024-04209-2.

An Update on Diabetic Foot Ulcer and Its Management Modalities.

Khan M, Jahan N, Khatoon R, Ansari F, Ahmad S Indian J Microbiol. 2024; 64(4):1401-1415.

PMID: 39678959 PMC: 11645353. DOI: 10.1007/s12088-023-01180-8.

Bacteriophage Therapy on an In Vitro Wound Model and Synergistic Effects in Combination with Beta-Lactam Antibiotics.

Santamaria-Corral G, Aguilera-Correa J, Esteban J, Garcia-Quintanilla M Antibiotics (Basel). 2024; 13(9).

PMID: 39334975 PMC: 11428794. DOI: 10.3390/antibiotics13090800.

Microbiological characterization of neuropathic diabetic foot infection: a retrospective study at a Portuguese tertiary hospital.

Goncalves J, Guimaraes A, Ferreira H, Ribeiro S, Moreno T, Borges-Canha M BMC Infect Dis. 2024; 24(1):791.

PMID: 39107703 PMC: 11305078. DOI: 10.1186/s12879-024-09677-3.

Is the Predominant Pathogen in Hospitalised Patients with Diabetes-Related Foot Infections: An Australian Perspective.

Morton K, Coghill S Antibiotics (Basel). 2024; 13(7).

PMID: 39061276 PMC: 11273989. DOI: 10.3390/antibiotics13070594.

References

Wagner Jr F . The diabetic foot. Orthopedics. 1987; 10(1):163-72. DOI: 10.3928/0147-7447-19870101-28. View

Levine N, LINDBERG R, MASON Jr A, PRUITT Jr B . The quantitative swab culture and smear: A quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma. 1976; 16(2):89-94. View

Pellizzer G, Strazzabosco M, Presi S, Furlan F, Lora L, Benedetti P . Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med. 2001; 18(10):822-7. DOI: 10.1046/j.1464-5491.2001.00584.x. View

Ndosi M, Wright-Hughes A, Brown S, Backhouse M, Lipsky B, Bhogal M . Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2017; 35(1):78-88. PMC: 5765512. DOI: 10.1111/dme.13537. View

Singh N, Armstrong D, Lipsky B . Preventing foot ulcers in patients with diabetes. JAMA. 2005; 293(2):217-28. DOI: 10.1001/jama.293.2.217. View

Vinik A, Maser R, Mitchell B, Freeman R . Diabetic autonomic neuropathy. Diabetes Care. 2003; 26(5):1553-79. DOI: 10.2337/diacare.26.5.1553. View

Menke A, Casagrande S, Geiss L, Cowie C . Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015; 314(10):1021-9. DOI: 10.1001/jama.2015.10029. View

Lipsky B, Aragon-Sanchez J, Diggle M, Embil J, Kono S, Lavery L . IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2015; 32 Suppl 1:45-74. DOI: 10.1002/dmrr.2699. View

Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M . Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008; 51(10):1826-34. DOI: 10.1007/s00125-008-1089-6. View

10.

Lipsky B, Berendt A, Cornia P, Pile J, Peters E, Armstrong D . 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012; 54(12):e132-73. DOI: 10.1093/cid/cis346. View

11.

Lipsky B . Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?. Clin Microbiol Infect. 2007; 13(4):351-3. DOI: 10.1111/j.1469-0691.2007.01697.x. View

12.

Lipsky B, Berendt A, Deery H, Embil J, Joseph W, Karchmer A . Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004; 39(7):885-910. DOI: 10.1086/424846. View

13.

Edmonds M, Foster A . The use of antibiotics in the diabetic foot. Am J Surg. 2004; 187(5A):25S-28S. DOI: 10.1016/S0002-9610(03)00300-3. View

14.

Lavery L, Armstrong D, Wunderlich R, Tredwell J, Boulton A . Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003; 26(5):1435-8. DOI: 10.2337/diacare.26.5.1435. View

15.

Lipsky B . A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev. 2004; 20 Suppl 1:S68-77. DOI: 10.1002/dmrr.453. View

16.

Nelson E, Backhouse M, Bhogal M, Wright-Hughes A, Lipsky B, Nixon J . Concordance in diabetic foot ulcer infection. BMJ Open. 2013; 3(1). PMC: 3549255. DOI: 10.1136/bmjopen-2012-002370. View

17.

Richard J, Lavigne J, Sotto A . Diabetes and foot infection: more than double trouble. Diabetes Metab Res Rev. 2012; 28 Suppl 1:46-53. DOI: 10.1002/dmrr.2234. View

18.

Slater R, Lazarovitch T, Boldur I, Ramot Y, Buchs A, Weiss M . Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med. 2004; 21(7):705-9. DOI: 10.1111/j.1464-5491.2004.01221.x. View

19.

Gardner S, Frantz R, Troia C, Eastman S, MacDonald M, Buresh K . A tool to assess clinical signs and symptoms of localized infection in chronic wounds: development and reliability. Ostomy Wound Manage. 2002; 47(1):40-7. View

20.

Schaper N . Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev. 2004; 20 Suppl 1:S90-5. DOI: 10.1002/dmrr.464. View